42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
    [defid] => VWS-WOO-08-1154267
    [request_id] => 
)

=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
    [id] => e2059137-2fde-4247-b117-41fb2d5c9f64
    [Document ID] => 1154267
    [Document naam] => ema-cover-leg002.docx
    [Bestandsnaam] => 
    [Beoordeling] => 
    [Beoordelingsgrond] => 
    [Toelichting] => 
    [Publieke link] => 
    [Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo/document/VWS-WOO-08-1154267
    [Opgeschort] => 
    [Definitief ID] => VWS-WOO-08-1154267
    [Status] => 
    [FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo
    [DocumentPublicationDate] => 18 februari 2021
    [DocumentStatusCheckedDate] => 
    [DocumentStatusCheckedResult] => 
    [SourceFileType] => 
    [Tags] => 
    [Besluit] => 
    [ModifiedDate] => 2025-09-22 06:34:58
    [DeletedDate] => 
    [BesluitURL] => 
    [CreatedDate] => 2025-06-19 18:31:59
    [DocumentDownloadLink] => 
    [DigestLaatsteControleDatum] => 2025-09-22 06:34:58
)

Document: VWS-WOO-08-1154267

Pagina 1 preview
Klik om te vergroten

Document correcties

Geregistreerde datum: 20210218

Geregistreerde documentnaam: ema-cover-leg002.docx

Document metadata

Metadata tonen (25 velden)
VeldWaarde
ide2059137-2fde-4247-b117-41fb2d5c9f64
Document ID1154267
Document naamema-cover-leg002.docx
Bestandsnaamleeg!
Beoordelingleeg!
Beoordelingsgrondleeg!
Toelichtingleeg!
Publieke linkleeg!
Locatie open.minvws.nlhttps://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo/document/VWS-WOO-08-1154267
Opgeschortleeg!
Definitief IDVWS-WOO-08-1154267
Statusleeg!
FromFilehttps://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo
DocumentPublicationDate18 februari 2021
DocumentStatusCheckedDateleeg!
DocumentStatusCheckedResultleeg!
SourceFileTypeleeg!
Tagsleeg!
Besluitleeg!
ModifiedDate2025-09-22 06:34:58
DeletedDateleeg!
BesluitURLleeg!
CreatedDate2025-06-19 18:31:59
DocumentDownloadLinkleeg!
DigestLaatsteControleDatum2025-09-22 06:34:58

🧙 User tags

Nog geen user tags

Document attributen

TagWaardeDatum
Request_Omvang openbaarmaking_linkname_1Inventarislijst2025-06-22 23:40:51
Request_Omvang openbaarmaking_documenten13.4182025-06-22 23:40:51
Request_Omvang openbaarmaking_paginas24.5512025-06-22 23:40:51
Request_Omvang openbaarmaking_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo/file/download/inventory2025-06-22 23:40:51
document_documentNameema-cover-leg002.docx2025-06-22 23:40:51
document_documentTypeWord-document2025-06-22 23:40:51
document_documentPublicationDate2021-02-182025-06-22 23:40:51
document_documentNumberVWS-WOO-08-11542672025-06-22 23:40:51
document_SectionDownloadButton02025-06-22 23:40:51
document_SectionHTMLDataDivs32025-06-22 23:40:51
document_SectionAbout12025-06-22 23:40:51
About_Datum document18 februari 20212025-06-22 23:40:51
About_Type bronbestandWord-document, 3 pagina's2025-06-22 23:40:51
About_Type bronbestand_paginas32025-06-22 23:40:51
About_Download alsPDF (1.06 MB)2025-06-22 23:40:51
About_Documentnummer11542672025-06-22 23:40:51
About_BeoordelingGedeeltelijke openbaarmaking2025-06-22 23:40:51
About_Gelakte gegevens5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten.2025-06-22 23:40:51
About_Gelakte gegevens_linkhref_1https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk52025-06-22 23:40:51
About_Gelakte gegevens_linkname_15.1.2e Eerbiediging van de persoonlijke levenssfeer2025-06-22 23:40:51
About_Gelakte gegevens_linkhref_2mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over ema-cover-leg002.docx (documentnummer 1ee694d7-e2b4-6bc8-b977-15d4a7a92981)2025-06-22 23:40:51
About_Gelakte gegevens_linkname_2Laat het ons weten2025-06-22 23:40:51
document_SectionRelated12025-06-22 23:40:51
document_SectionRequest12025-06-22 23:40:51
Request_Onderdeel vanWoo-deelbesluit aangaande Vaccinaties en Medicatie over de periode februari 20212025-06-22 23:40:51
Request_Onderdeel van_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo2025-06-22 23:40:51
Request_Onderdeel van_linkname_1Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode februari 20212025-06-22 23:40:51
Request_Samenvatting verzoekDe minister van Volksgezondheid, Welzijn en Sport heeft op 21 december 2022 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en Medicatie over de periode februari 2021.2025-06-22 23:40:51
Request_PeriodeFebruari 20212025-06-22 23:40:51
Request_Type besluitWoo-besluit2025-06-22 23:40:51
Request_Datum besluit21 december 20222025-06-22 23:40:51
Request_Omvang openbaarmaking13.418 documenten, 24.551 pagina's Inventarislijst2025-06-22 23:40:51
DocumentDownload_linkhrefhttps://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo/file/download/document/1ee694d7-e2b4-6bc8-b977-15d4a7a929812025-04-19 22:17:07
DocumentDownload_proposed_filename (lokale kopie)VWS-WOO-08-1154267.pdf2025-04-19 22:17:07
DocumentDownload_linknameDownload (pdf, 1.06 MB)2025-04-19 22:17:07

Archiefversies (7 rijen)

Archiefrij 1 — 2025-10-22 14:09:58
fromFile: VWS-WOO-3478791-1040904-pdo-1f0a5062-ca80-6d9e-ad03-555512cbea5c.zip
fromFilePath: /volume3/websites/openrijksoverheid/archieven_files/VWS-WOO-3478791-1040904-pdo-1f0a5062-ca80-6d9e-ad03-555512cbea5c.zip
documentName: VWS-WOO-08-1154267.pdf
documentType: pdf
documentCompressedSize: 688817
documentSize: 1114030
documentCompressRatio: 61.83109970108524
documentDateModified: 2025-10-09 11:54:18
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-10-22 14:09:58
lastSeen: 2025-10-22 14:09:58
text: 1154267 AstraZeneca AstraZeneca AB SE-151 85 Sddertélje, Sweden T. +46 8 553 260 00 F. +46 8 553 290 00 astrazeneca.com Product and Application Business Support (PA-BUS) European Medicines Agency Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands 18 February 2021 C...
noTextDate: leeg!
ocrText: Datum: vrijdag 20 augustus 2021 12:16:00 Beste ‚ Eigenlijk zou ik hierover graag een afspraak aan tafel willen. Ik wil graag weten wat de inspectie allemaal doet op dit moment, of dat het hele repertoire is, en of dat echt full force wordt ingezet. Verhalen die de ronde doen (hoor ik uiteraard sl...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 997586261050f8766cb6f7b2bae62327db355accfe879e3619b2e67d23855f38
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: VWS-WOO-3478791-1040904-pdo-1f0a5062-ca80-6d9e-ad03-555512cbea5c.zip_1953
textDigestSHA256: df6377093b2e56ea23e56eb81af345fe6f3c5cc1d36ca351a6da063435b95f8e
ocrTextDigestSHA256: 0a8c0a926625c74214e56cdceb471d6743facdaf9a019f0c13d9c21860bda4bf
extractedId: VWS-WOO-08-1154267
Archiefrij 2 — 2025-09-07 17:27:15
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1154267.pdf
documentName: VWS-WOO-08-1154267.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 1114030
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:27:15
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:27:15
lastSeen: 2025-09-07 17:27:15
text: Product and Application Business Support (PA-BUS) European Medicines Agency Domenico Scarlattilaan 6 1083 HSAmsterdam The Netherlands 18"February 2021 ConfidentialAstraZeneca AstraZeneca AB SE-151 85Sddertélje, Sweden T.+46 8553 260 00 F.+46 8553 290 00 astrazeneca.com Subject: Monthly Update forLEG...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 997586261050f8766cb6f7b2bae62327db355accfe879e3619b2e67d23855f38
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_52115_8ca4b55c075c84df033199fc37bc8519
textDigestSHA256: 1c475039414b671cecf694ecbc86c7b03c42906e163ff1f357df5a39cc827d06
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1154267
Archiefrij 3 — 2025-09-04 17:04:53
fromFile: VWS-WOO-3478791-1040904-pdo-1f026c98-b2f7-6926-8f52-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3478791-1040904-pdo-1f026c98-b2f7-6926-8f52-65673e0af118.zip
documentName: VWS-WOO-08-1154267.pdf
documentType: pdf
documentCompressedSize: 688817
documentSize: 1114030
documentCompressRatio: 61.83109970108524
documentDateModified: 2025-05-01 20:32:48
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:04:53
lastSeen: 2025-09-04 17:04:53
text: Product and Application Business Support (PA-BUS) European Medicines Agency Domenico Scarlattilaan 6 1083 HSAmsterdam The Netherlands 18"February 2021 ConfidentialAstraZeneca AstraZeneca AB SE-151 85Sddertélje, Sweden T.+46 8553 260 00 F.+46 8553 290 00 astrazeneca.com Subject: Monthly Update forLEG...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 997586261050f8766cb6f7b2bae62327db355accfe879e3619b2e67d23855f38
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: VWS-WOO-3478791-1040904-pdo-1f026c98-b2f7-6926-8f52-65673e0af118.zip_467
textDigestSHA256: 1c475039414b671cecf694ecbc86c7b03c42906e163ff1f357df5a39cc827d06
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1154267
Archiefrij 4 — 2025-03-18 09:30:25
fromFile: 2024.075-VWS-WOO-3478791-1040904-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3478791-1040904-pdo.zip
documentName: VWS-WOO-08-1154267-ema-cover-leg002.docx.pdf
documentType: pdf
documentCompressedSize: 686795
documentSize: 1114030
documentCompressRatio: 61.64959650996832
documentDateModified: 2024-11-19 14:56:36
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:25
lastSeen: 2025-03-18 09:30:25
text: Product and Application Business Support (PA-BUS) European Medicines Agency Domenico Scarlattilaan 6 1083 HSAmsterdam The Netherlands 18"February 2021 ConfidentialAstraZeneca AstraZeneca AB SE-151 85Sddertélje, Sweden T.+46 8553 260 00 F.+46 8553 290 00 astrazeneca.com Subject: Monthly Update forLEG...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 1c475039414b671cecf694ecbc86c7b03c42906e163ff1f357df5a39cc827d06
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 340033
textDigestSHA256: 1c475039414b671cecf694ecbc86c7b03c42906e163ff1f357df5a39cc827d06
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1154267
Archiefrij 5 — 2025-02-27 09:25:05
fromFile: 2023.057-VWS-WOO-3478791-1040904-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3478791-1040904-pdo.zip
documentName: VWS-WOO-08-1154267-ema-cover-leg002.docx.pdf
documentType: pdf
documentCompressedSize: 686795
documentSize: 1114030
documentCompressRatio: 61.64959650996832
documentDateModified: 2024-11-19 14:56:36
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:05
lastSeen: 2025-02-27 09:25:05
text: Product and Application Business Support (PA-BUS) European Medicines Agency Domenico Scarlattilaan 6 1083 HSAmsterdam The Netherlands 18"February 2021 ConfidentialAstraZeneca AstraZeneca AB SE-151 85Sddertélje, Sweden T.+46 8553 260 00 F.+46 8553 290 00 astrazeneca.com Subject: Monthly Update forLEG...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 3032, "email": "@2strazeneca.com", "context": "aFax E- ail:[EEN @2strazeneca.com Onbehalf ofAstraZeneca AB"}]
documentMailAdresses: [{"position": 3032, "email": "@2strazeneca.com", "context": "aFax E- ail:[EEN @2strazeneca.com Onbehalf ofAstraZeneca AB"}]
digestSHA256: 1c475039414b671cecf694ecbc86c7b03c42906e163ff1f357df5a39cc827d06
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 253121
textDigestSHA256: 1c475039414b671cecf694ecbc86c7b03c42906e163ff1f357df5a39cc827d06
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1154267
Archiefrij 6 — 2025-02-18 12:18:13
fromFile: Besluit__dossier_nr_-6c83ab2d51cf026ac610ece2faff887a7ba1a1fe4e877e2c6b36655c00305357.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-6c83ab2d51cf026ac610ece2faff887a7ba1a1fe4e877e2c6b36655c00305357.zip
documentName: VWS-WOO-08-1154267-ema-cover-leg002.docx.pdf
documentType: pdf
documentCompressedSize: 686795
documentSize: 1114030
documentCompressRatio: 61.64959650996832
documentDateModified: 2024-11-19 14:56:36
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: Product and Application Business Support (PA-BUS) European Medicines Agency Domenico Scarlattilaan 6 1083 HSAmsterdam The Netherlands 18"February 2021 ConfidentialAstraZeneca AstraZeneca AB SE-151 85Sddertélje, Sweden T.+46 8553 260 00 F.+46 8553 290 00 astrazeneca.com Subject: Monthly Update forLEG...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 3032, "email": "@2strazeneca.com", "context": "aFax E- ail:[EEN @2strazeneca.com Onbehalf ofAstraZeneca AB"}]
documentMailAdresses: [{"position": 3032, "email": "@2strazeneca.com", "context": "aFax E- ail:[EEN @2strazeneca.com Onbehalf ofAstraZeneca AB"}]
digestSHA256: 1c475039414b671cecf694ecbc86c7b03c42906e163ff1f357df5a39cc827d06
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 122745
textDigestSHA256: 1c475039414b671cecf694ecbc86c7b03c42906e163ff1f357df5a39cc827d06
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1154267
Archiefrij 7 — 2025-02-18 12:18:00
fromFile: Besluit__dossier_nr_-059f008949175bc5c1c05e6900ee06a7b0f3f1edfa07b5d2ec14c9ecfa5c5bc7.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-059f008949175bc5c1c05e6900ee06a7b0f3f1edfa07b5d2ec14c9ecfa5c5bc7.zip
documentName: VWS-WOO-08-1154267-ema-cover-leg002.docx.pdf
documentType: pdf
documentCompressedSize: 686795
documentSize: 1114030
documentCompressRatio: 61.64959650996832
documentDateModified: 2024-08-30 08:50:38
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:00
lastSeen: 2025-02-18 12:18:00
text: Product and Application Business Support (PA-BUS) European Medicines Agency Domenico Scarlattilaan 6 1083 HSAmsterdam The Netherlands 18"February 2021 ConfidentialAstraZeneca AstraZeneca AB SE-151 85Sddertélje, Sweden T.+46 8553 260 00 F.+46 8553 290 00 astrazeneca.com Subject: Monthly Update forLEG...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 3032, "email": "@2strazeneca.com", "context": "aFax E- ail:[EEN @2strazeneca.com Onbehalf ofAstraZeneca AB"}]
documentMailAdresses: [{"position": 3032, "email": "@2strazeneca.com", "context": "aFax E- ail:[EEN @2strazeneca.com Onbehalf ofAstraZeneca AB"}]
digestSHA256: 1c475039414b671cecf694ecbc86c7b03c42906e163ff1f357df5a39cc827d06
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 23549
textDigestSHA256: 1c475039414b671cecf694ecbc86c7b03c42906e163ff1f357df5a39cc827d06
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1154267

(dit is ook een speeltuin)